Tenders/Daratumumab - Solution for injection - vial - 1800 mg/15 ml
Awarded🇧🇬BulgariaSupplies

Daratumumab - Solution for injection - vial - 1800 mg/15 ml

Auto-translated from bg
Original title: Daratumumab -Solution for injection -fl. -1800 mg/15 ml
УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД
Published: Sep 15, 2026
Updated: Sep 18, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to СОФАРМА ТРЕЙДИНГ АД — €5,521,384

Browse open Health & Medical tenders in Bulgaria

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.7 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from bg
ATC code / INN / Dosage form / Unit / Active substance quantity / Forecast quantity for 12 months L01FC01 - Daratumumab - Solution for injection - vial - 1800 mg/15 ml - 420 Note: Any specific mention of a standard, specification, technical assessment, technical approval or technical benchmark in these technical specifications shall be deemed to be supplemented by the words "or equivalent/s". Requirements for medicinal products: 1. Medicinal products must comply with the requirements of the Human Medicinal Products Act (ZLPXM) - they must have a valid marketing authorization in the country, issued in accordance with the ZLPXM or Regulation (EC) No 726/2004 of the European Parliament and of the Council (Art. 23, para. 1 of ZLPXM). In case the marketing authorization of a medicinal product expires during the relevant year for which the public procurement is conducted, the participant declares in accordance with Art. 55, para. 6 of ZLPXM that the quantities of medicinal products are available. 2. Medicinal products must be included in Annex No. 2 of the PLS. The proposed price per package cannot be higher than the one indicated in the annex "package value, proposed based on reference value" (according to Art. 55 of the "Ordinance on the conditions, rules and procedures for regulating and registering prices of medicinal products", amended and supplemented, DV. No. 8 of January 24, 2017), current as of the deadline for submitting offers. The proposed price per package cannot be higher than the value that the NHIF pays for the same package. Medicinal products must have prices per unit of measure (mg, mcg, etc.) equal to or lower than the prices that the NHIF will pay to the healthcare facility for the specific medication, in accordance with the current regulatory framework - Health Insurance Act, Ordinance No. 10 of 2009 on the conditions, procedure, mechanism and criteria for payment by the National Health Insurance Fund for medicinal products, medical devices and foods for special medical purposes and assistive devices, appliances, equipment and medical devices for people with disabilities, negotiation of discounts and recovery of excess funds when applying a mechanism guaranteeing predictability and sustainability of the NHIF budget, etc. 3. The offered medicinal products for the lots must comply with the data from the technical and price proposal template from the participation documentation. 4. As of the date of delivery, the remaining shelf life must be not less than 40% of that declared by the manufacturer, and for biological medicinal products, not less than 25% of that declared by the manufacturer. 5. The medicinal products offered by the participant must have a summary of product characteristics in Bulgarian and contain information according to Art. 34, para. 1 of ZLPXM. 6. The packaging of the medicinal products must comply with the requirements of Chapter VI "Packaging and leaflets of medicinal products" of ZLPXM.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 15, 2026. Last refreshed 61 days ago. Original language: bg. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД

УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД has issued 141 procurement notices on BidsFactory, including 4 currently open and 129 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Architecture & Engineering Services. All notices are published for Bulgaria. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: November 18, 2026.

УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД: buyer profile, tenders and awards

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

СОФАРМА ТРЕЙДИНГ АД was awarded the contract for €5,521,384. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Bulgaria. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to СОФАРМА ТРЕЙДИНГ АД. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД in Bulgaria. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Estimated Budget
€1,725,941
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
bg

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД
🇧🇬Bulgaria